Cite

HARVARD Citation

    Cogle, C. et al. (2015). Oral Azacitidine (CC‐486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia. Oncologist. pp. 1404-1412. [Online]. 
  
Back to record